HomeCare December 9, 2024
The English company gained $33 million in its latest Series C funding round, which aims to secure U.S. reimbursement for its wound care products & continuous topical oxygen therapy technologies
CAMBRIDGE, England—Inotec AMD, a medical equipment manufacturer, announced the close of its $33 million Series C financing round. The company said this funding—led by investors Amadeus Capital Partners, Meltwind, Puhua Capital and the Wealth Club—intends to further its mission to heal chronic wounds and improve patients’ lives on a global scale.
The company said the proceeds from this funding round will be used to secure national reimbursement in the U.S. for the company’s advanced wound care product “Natrox O2,” as well as to ensure broader product accessibility for patients across...
Today's Sponsors
Today's Sponsor